Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-24-157521

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d835355d8k.htm…